Related Experiment Video
Updated: Jul 19, 2026

In vivo Imaging of Transgenic Leishmania Parasites in a Live Host
Published on: July 27, 2010
[CD8+ cytotoxic lymphocytes in cutaneous leishmaniasis]
Joselín Hernández-Ruiz1, Ingeborg Becker
1Departamento de Medicina Experimental, Facultad de Medicina, Universidad Nacional Autónoma de Mexico, México, DF. hernandezjoselin@yahoo.com.mx
Insights
CD8+ T cells are crucial in fighting Leishmania parasites causing cutaneous leishmaniasis. Understanding their activation mechanisms, possibly involving dendritic cells, could reveal new therapeutic strategies for this neglected tropical disease.
Area of Science:
- Immunology
- Parasitology
- Cellular Biology
Context:
- Cutaneous leishmaniasis is a significant global health concern caused by Leishmania species.
- While other immune cells like macrophages, dendritic cells, CD4 T cells, and NK cells are well-studied, the role of CD8+ T cells remains less understood.
- Existing research, primarily from murine models, indicates CD8+ T cells contribute through Interferon-gamma (IFN-γ) production and potentially cytotoxic activity, as observed in human cases.
Purpose:
- To review the current literature on the function of CD8+ T cells in the immune response against Leishmania species responsible for cutaneous leishmaniasis.
- To highlight the knowledge gaps concerning CD8+ T T cell involvement and activation pathways in leishmaniasis.
- To explore potential mechanisms of CD8+ T cell activation, such as antigen presentation by dendritic cells.
Summary:
- CD8+ T cells play a vital role in the immune defense against Leishmania parasites.
- Both IFN-γ production and cytotoxic functions of CD8+ T cells are implicated in controlling cutaneous leishmaniasis.
- The precise mechanisms of CD8+ T cell activation in this disease are not fully elucidated but may involve dendritic cell-mediated antigen presentation.
Impact:
- A deeper understanding of CD8+ T cell roles can illuminate the physiopathology of leishmaniasis.
- This knowledge may pave the way for novel therapeutic interventions and treatment strategies for cutaneous leishmaniasis.
- Identifying key activation pathways could lead to targeted immunotherapies to enhance protective immunity.
Objective:
Review of the literature on the role of CD8+ T cell in the immune response against Leishmania species that cause cutaneous leishmaniasis. The role of macrophages, dendritic cells, CD4 T cells and NK cells has been extensively analyzed in leishmaniasis, yet very little knowledge has been gained on CD8+ T cells in this disease. Murine models of leishmaniasis suggest that CD8+ T cells participate through IFNg production, yet their cytotoxic capacity may also play a crucial role, as has been found in human disease. It is an enigma what mechanisms underlie the CD8+ T cell activation. It is possible that dendritic cells activate CD8+ T cells through mechanisms that include antigen traspresentation. A better understanding of CD8+ T cells in the immune response against Leishmania will undoubtedly provide new insights into the physiopathogenesis of the disease that could lead to new therapeutic approaches against leishmaniasis.
Related Concept Videos
Leishmaniasis
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Antiprotozoal Agents
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...